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Persistence of Orientia tsutsugamushi in Humans
We investigated the persistence of viable Orientia tsutsugamushi in patients who had 
recovered from scrub typhus. Blood specimens were available from six patients with scrub 
typhus who were at 1 to 18 months after the onset of the illness. The EDTA-treated blood 
specimens were inoculated into ECV304 cells, and cultures were maintained for 7 months. 
Sequencing of the 56-kDa type-specific antigen gene of O. tsutsugamushi was performed 
to ascertain the homology of isolates. O. tsutsugamushi was isolated from all six patients, 
and nucleotide sequences of isolates serially collected from each patient were identical in 
all five patients in whom nucleotide sequences were compared. One patient relapsed 2 
days after completion of antibiotic therapy; two patients complained of weakness for 1 to 
2.5 months after the illness; one patient underwent coronary angioplasty 6 months later; 
and one patient suffered from a transient ischemic attack 8 months later. This finding 
suggests that O. tsutsugamushi causes chronic latent infection, which may be associated 
with certain clinical illnesses, preceded by scrub typhus. Antibiotic therapy abates the 
symptoms of scrub typhus, but does not eradicate O. tsutsugamushi from the human 
body.
Key Words: Orientia tsutsugamushi; Scrub typhus; Persistence; Recurrence; 
Atherosclerosis
Moon-Hyun Chung
1, Jin-Soo Lee
1, 
Ji-hyeon Baek
1, Mijeong Kim
1, 
and Jae-Seung Kang
2
1Departments of Internal Medicine, 
and 
2Microbiology, Inha University School of 
Medicine, Incheon, Korea
Received: 9 October 2011
Accepted: 3 January 2012
Address for Correspondence:
Jae-Seung Kang, MD 
Department of Microbiology, Inha University School of Medicine, 
27 Inhang-ro, Jung-gu, Incheon 400-712, Korea
Tel: +82.32-890-0952, Fax: +82.32-881-8559
E-mail: jaeskang@inha.ac.kr
A part of the present study was presented at the annual 
meeting of the Korean Society of Infectious Diseases in 2009.
http://dx.doi.org/10.3346/jkms.2012.27.3.231  •  J Korean Med Sci 2012; 27: 231-235
ORIGINAL ARTICLE
Infectious Diseases, Microbiology & Parasitology
INTRODUCTION
Scrub typhus, also known as tsutsugamushi disease, is caused 
by Orientia tsutsugamushi, which is considered to be an acute 
infectious disease and to be successfully cured with antibiotics. 
Studies using the polymerase chain reaction (PCR) reveal that 
O. tsutsugamushi DNA in blood disappears gradually over 1 
month after antibiotic treatment (1-4). It has not been clarified 
whether the DNA detected by PCR after the disappearance of 
symptoms of scrub typhus represents dead or viable bacteria, 
and its relevance and clinical significance have not been inves-
tigated. Although isolation of O. tsutsugamushi beyond 1 month 
after scrub typhus in humans has been reported sometimes (5-
7), these cases are thought to be exceptional. Contrast to the short 
duration of scrub typhus in humans, persistence of O. tsutsuga-
mushi is a common finding in mice (8-14). Ability of O. tsutsu-
gamushi to persist in cell culture assay is also documented (15). 
Chloramphenicol and tetracyclines show bacteriostatic effects 
against O. tsutsugamushi in mice (10, 16); therefore, theoretical-
ly antibiotics cannot eradicate the bacterium from the human 
body. Although the immune system is known to be involved in 
the recovery of an individual from scrub typhus and in protec-
tion from rechallenge of O. tsutsugamushi (17), it is never been 
proven that this system can completely eradicate O. tsutsuga-
mushi from the human body. In the present study, we investi-
gated the persistence of viable O. tsutsugamushi and its associa-
tion with any clinical or laboratory abnormalities in patients 
who had recovered from scrub typhus.
   
MATERIALS AND METHODS
Patients
Blood specimens beyond 30 days after the onset of fever (defined 
as ‘chronic phase’) were available from 6 patients. Five patients 
(patient No. 1 to 5) were followed from the onset of scrub typhus 
diagnosed at our hospital between 2008 and 2009, and 1 patient 
(patient No. 6) was during follow up of other chronic illnesses 
after scrub typhus. Scrub typhus was diagnosed by the presence 
of fever and positive serology or blood nested PCR that was per-
formed as described previously (3). Clinical and laboratory char-
acteristics of the patients are summarized in Table 1. 
In vitro culture and immunofluorescent staining
Details of cell culture and immunofluorescent (IF) staining were 
described previously (15). Briefly, 0.3 mL of EDTA-treated whole 
blood was inoculated into a monolayer of ECV304 cells (18) 
grown in a tissue culture flask (25 cm
2). Twenty-four hours later, 
the inoculated blood was washed out with phosphate buffered 
saline, and culture was maintained in M199 medium (Gibco 
BRL, Gaithersburg, MD, USA) supplemented with 10% heat-in-
activated fetal bovine serum (Gibco BRL) at 37°C in a humidi-
fied atmosphere containing 6% CO2. Media were changed every Chung M-H, et al.  •  Persistence of Orientia tsutsugamushi in Humans
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3 to 4 days, and cultures were maintained for 7 months without 
subculture. During the maintenance of the cell culture, cell cul-
tures were inspected daily with optical microscopy (Olympus, 
Tokyo, Japan). After cytopathic changes were identified, a small 
amount of the ECV304 monolayer was aspirated with a pipette, 
and IF staining of the aspirate was performed with mouse poly-
clonal hyperimmune serum against the Boryong strain of O. 
tsutsugamushi. For negative control, blood from 5 healthy per-
sons and 5 patients with unrelated illnesses (cerebrovascular 
accident [n = 2]; acute myocardial infarction [n = 2]; and diabe-
tes mellitus [n = 1]) were processed as the same manner.
Polymerase chain reaction and sequencing of 56-kDa gene
To identify the genotype of cultured isolates and to compare nu-
cleotide sequences of the isolates, the 56-kDa type-specific anti-
gen (TSA56) gene of O. tsutsugamushi was amplified using PCR 
and then sequenced. Genomic DNA from the infected ECV304 
cells was prepared with QIAamp DNA Mini kit (QIAGEN, Hilden, 
Germany) according to the manufacturer’s instruction. PCR in 
detail was described previously (19). The primer set used for the 
amplification of the first half TSA56 gene of O. tsutsugamushi 
were primer 1 (forward) (5´-TTTCGAACGTGTCTTTAAGC-3´; 
corresponding to nucleotide position -266 to -285 from the start 
codon of the 56-kDa gene based on the Gilliam strain) and prim-
er 2 (reverse) (5´-ACAGATGCACTATTAGGCAA-3´; 847-865). 
Primer 3 (forward) (5´-ATGCTAATAAACCTAGCGCT-3´; 731-
749) and primer 4 (reverse) (5´-CTAGAAGTTATAGCGTACACC-
TGCACTTGC-3´; 1546-1575) were used for amplification of the 
second half one. Primer 9 (5´-GTTTAGAATGGTTACCAC-3´; 
-36 to -53) and primer 7 (5´-AGCGCTAGGTTTATTAGCAT-3´; 
731-749) were used for sequencing of the amplified first half of 
the TSA56 gene, and primer 8 (5´-TCCACATACACACCTTCA-
GC-3´; 1459-1478) and primer 10 (5´-CCTAGCGTTACTCCT-
GTCAAAG-3´; 742-763) were used for the amplified second half 
of the TSA56 gene. The first half of the TSA56 gene was amplified 
in a 50-μL reaction mixture consisting of 5 μL of template DNA, 
250 μM (each) deoxynucleotide triphosphate, 200 μM each of 
primers 1 and 2, 1.25 U of Taq polymerase and 5 μL of 10 ×  PCR 
buffer (Takara Shuzo Co., Kyoto, Japan) in a Perkin-Elmer model 
9600 thermocycler (Perkin-Elmer Cetus Instruments, Norwalk, 
Table 1. Characteristics, clinical features, and laboratory results of the patients
Patient 
No.
Sex/ 
age
 (yr)
Underlying  
illness
Antibiotics,  
duration of  
treatment
Duration 
after the 
onset of 
scrub  
typhus
Clinical feature, laboratory finding, and genotype of O. tsutsugamushi when blood specimen was obtained
Fever/eschar/
rash
WBC  
(/μL)
CRP 
(mg/L)
ESR 
(mm/h)
AST/ALT 
(IU/L)
Anti- 
Orientia 
antibody 
(reciprocal 
titer)
Blood  
nested 
PCR 
Cell culture/genotype of 
the isolate (GenBank  
accession number)/day  
to identify the growth of  
O. tsutsugamushi firstly 
1 F/59 Hypertension Azithromycin, 7 d; 
doxycycline, 7 d
7 d
 
1 m
+/+/+; shock,  
pneumonia
Weakness,  
anorexia
5,100
4,290
310
 
1.0
8
 
36
230/149
 
31/102
1,280
 
2,560
Positive
 
Positive
Positive/Yonchon
(HQ660209)/63 d
Positive/Yonchon  
(HQ660210)/83 d
2 F/48 None Azithromycin, 3 d
Doxycycline, 10 d
13 d
2.5 m
+/+/+
Weakness
ND
3,800
ND
0.5
ND
11
ND
28/16
ND
320
ND
Positive
ND
Positive/Boryong 
(HQ660214)/53 d
3 F/69 Diabetes Azithromycin, 3 d 17 d
27 d
5 m
8 m
+/+/-
None
 
None
None
5,400 
6,400
5,600
5,700
ND
ND
0.3
0.3
ND
ND
14
16
72/53
22/25
 
24/15
23/14
160
320
160
80
Positive
Positive
Negative
Negative
Positive/Boryong
(HQ660198)/51 d
Positive/Boryong
(HQ660199)/ 63 d
Positive/Boryong
(HQ660200)/ 70 d
Positive/Boryong
(HQ660211)/ 118 d
4 F/89 Hypertension Doxycycline, 10 d 10 d
2.5 m
4 m 
+/+/+
None
None
7,200
5,200
3,900
150
1
Negative
48
106
61
311/225
21/14
27/22
160
320
40
ND
Positive
Positive
ND
Positive/Boryong
(HQ660201)/79 d
Positive/Boryong
(HQ660202)/ 104 d
5 F/31 Microscopic 
hematuria, 
thyroid cancer
Azithromycin, 10 d 6 d
4 m
+/-/-;
pneumonia
None
6,600
9,600
48
4
21
25
17/19
10/6
80
160
Positive
Negative
Positive/Karp
(HQ660203)/119 d
Positive/Karp
(HQ660204)/193 d
6
 
M/62 Hypertension, 
coronary heart 
disease, 
cerebral  
infarction
Doxycycline, 10 d 12 d
18 m
+/+/+
None
4,400
ND
53
0.8
12
12
108/156
29/34
320
160
ND
Negative
Positive/Boryong
(HQ660212)/ no record
Positive/Boryong
(HQ660213)/ 200 d
+/-, present/absent; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CRP, C-reactive protein; d, days; ESR, erythrocyte sedimentation rate; m, months; ND, not 
done; PCR, polymerase chain reaction.Chung M-H, et al.  •  Persistence of Orientia tsutsugamushi in Humans
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CT, USA). The mixture was incubated in the thermal cycler at 
94°C for 5 min, then cycled 30 times at 94°C for 1 min, at 55°C 
for 1.5 min, at 72°C for 2 min, and finally once at 72°C for 7 min. 
Amplification of the second half of the TSA56 gene was performed 
as described above except that primers 3 and 4 were used and 
the annealing period was shortened to 1 min instead of 1.5 min. 
The amplified products were electrophoresed in 1.5% agarose 
gels, purified with the QIAquick kit (QIAGEN), and sequenced 
by the single-pass sequencing method using the BigDye termi-
nator cycle sequencing reaction kit and ABI PRISM 3700 & 3730xl 
automatic sequencer (Applied Biosystems, Foster City, CA, USA). 
All sequencing reactions were performed at least twice. Geno-
types of the isolates were determined by identifying a represen-
tative strain revealing a maximum pairwise identity score with 
the TSA56 gene from the GenBank (National Institutes of Health, 
Bethesda, MD, USA), and sequence homology of the isolates 
were examined by pairwise comparisons using BLAST (National 
Institutes of Health).
Ethics statement
The study protocol was approved by the institutional review 
board of Inha University Hospital (IRB No. 11-1839). Informed 
consent was confirmed by the board.
 
RESULTS
All six patients revealed O. tsutsugamushi in blood culture in the 
afebrile state at 1 to 18 months after scrub typhus (Table 1). The 
genotypes of isolates were the Boryong in five patients (patients 
2, 3, 4, and 6) and non-Boryong genotypes in two patients (Yon-
chon from patient 1 and Karp from patient 5). Nucleotide se-
quences of isolates serially collected from each patient were 
identical in all five patients in whom nucleotide sequences were 
compared. Nucleotide sequences of 9 isolates typed as the Bo-
ryong were 99% to 100% homologous, thus it is less helpful to 
differentiate each other; however, 2 isolates of the Yonchon and 
2 isolates of the Karp types were distinctively different from other 
isolates. From 5 healthy persons and 5 patients with unrelated 
illnesses, no organism was isolated.
  Patient 1, who presented with shock and was managed with 
steroid in addition to azithromycin, experienced a relapse 2 days 
after completion of 7-days’ azithromycin therapy; treatment with 
doxycycline abated fever. Patients 1 and 2 complained of weak-
ness in the absence of fever for 1 to 2.5 months after the illness 
and revealed positive blood nested PCRs; patient 1 showed ab-
normal aminotransferase level on day 31; and patient 2 revealed 
leukopenia on day 73, and retreatment with doxycycline resulted 
in improvement of weakness over 5 days. Patient 4 showed ele-
vated erythrocyte sedimentation rate and positive PCRs 2 times 
over 4 months and experienced a transient ischemic attack (TIA) 
8 months after scrub typhus. Patient 6, who had been managed 
with angina pectoris, experienced dizziness of cardiac origin 
and underwent percutaneous coronary angioplasty 6 months 
after scrub typhus.
   
DISCUSSION
Asymptomatic harboring of O. tsutsugamushi or its DNA is fre-
quently observed in animals, and these data are regarded as to 
represent an indirect evidence of persistent O. tsutsugamushi 
infection. For example, Jackson et al. (8) isolated O. tsutsuga-
mushi from 12 (13.2%) among 91 wild rodents in Korea. Using 
PCR, O. tsutsugamushi DNA was detected in 12 (9.5%) among 
127 wild rodents (9). In studies with experimentally infected 
mice, persistence of O. tsutsugamushi was more clearly demon-
strated (10-13). Using mouse inoculation, persistence of viable 
O. tsutsugamushi is documented for up to 100 (10), 270 (11), and 
610 days (12), irrespective of antibiotic therapy. Nested PCR also 
revealed persistence of O. tsutsugamushi DNA until 64 days after 
infection (13).
  On the contrary, there have been few studies on the persis-
tence of O. tsutsugamushi in human. Hayashi and Watanabe (5) 
detected O. tsutsugamushi bacteremia in a patient who was at 
34 days after defervescence. The Pescadores strain of O. tsutsu-
gamushi was isolated from a patient at 5 months after scrub ty-
phus (6). Smadel et al. (7) recovered O. tsutsugamushi from the 
lymph nodes of 1 person among 12 who had experienced scrub 
typhus 1 to 2 yr previously. Because these 3 reports were per-
formed before the introduction of modern technology, identifi-
cation of isolates is not sufficient to affirm the homology of iso-
lates. In volunteers experimentally infected by laboratory-reared 
chiggers, rickettsemia was present until 22 days after the infec-
tion (20). Thereafter, attempts to isolate viable O. tsutsugamushi 
from patients have seldom been tried.
  Instead, in recent years, PCR has been used to show that O. 
tsutsugamushi DNA disappeared gradually over 5 to 27 days after 
administration of antibiotics and reaffirmed short duration of 
O. tsutsugamushi bacteremia in human (1-4). These PCR data 
were contrasted to the result of the present study, and the main 
reason for the difference is thought to be low sensitivity of PCR. 
Nested PCR is very sensitive enough to detect 10 attogram (10
-18 
g), i.e., 1 copy, of O. tsutsugamushi DNA, if it is performed by an 
experienced person and using Southern blot hybridization. 
However, if agarose gel electrophoresis is used, which was used 
in the above PCR studies, the sensitivity is lowered by 10
3. Addi-
tionally, if clinical specimens such as blood or spleen are exam-
ined, it can lower the sensitivity of PCR further (13). Among the 
above PCR studies, only 1 study described that the detection 
threshold of the study method was 100 femtogram (10
-15 g), i.e., 
10
4 copies, of O. tsutsugamushi DNA (2). The quantity of O. tsu-
tsugamushi in blood during scrub typhus, which was evaluated 
by real-time PCR, varies from undetectable level during days Chung M-H, et al.  •  Persistence of Orientia tsutsugamushi in Humans
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1-4 to up to 10
6 copies per mL during days 9-12; and the detec-
tion limit of the real-time PCR was 1,062 target gene copies per 
mL of EDTA blood (21). We assume that the quantity of O. tsu-
tsugamushi in blood during the chronic phase is below the quan-
tity during days 1 to 4. Thus, nested PCR employed in clinical 
practice cannot detect O. tsutsugamushi DNA during the chron-
ic phase in most scrub typhus patients. More importantly, the 
reason that the PCR studies did not detect O. tsutsugamushi 
DNA beyond 1 month of scrub typhus is that there has been lit-
tle attempt to detect DNA beyond 1 month after the onset of 
scrub typhus (1-4, 21). Our study confirmed that the remaining 
DNA beyond the symptomatic period of scrub typhus was due 
to viable O. tsutsugamushi.
  We used in vitro culture technique in addition to PCR. Cell 
culture has several disadvantages, such as requirement of long 
incubation, infectious hazard, and inability to detect dead or-
ganism; however, theoretically it can detect even 1 viable organ-
ism in blood. Regardless of which method is more sensitive, our 
study revealed a high isolation rate of O. tsutsugamushi during 
the chronic phase. One concern is laboratory contamination of 
cell culture during long incubation; however, this possibility can 
be excluded by the following reasons: firstly, our laboratory has 
about two decades’ experiences in cultivating O. tsutsugamushi 
and maintains the contamination rate as minimal. Cell culture 
is not intrinsically prone to contamination as PCR, and if con-
tamination occurs, bacterial contamination is more likely, and 
in turn culture is grossly spoiled. Secondly, nucleotide sequences 
of the isolates were identical within each patient, but different 
between patients infected by different genotypes. Lastly, cul-
ture from control persons did not revealed any organism.
  Although the persistence of O. tsutsugamushi and its clinical 
significance in humans are firstly documented in the present 
study, persistence of Rickettsia prowazekii, a bacterium closely 
related to O. tsutsugamushi, in humans is well known, and Brill-
Zinsser disease is a relapse of latent R. prowazekii infection. Like-
wise, persistent O. tsutsugamushi infection is associated with 
certain illnesses. It is already known that ‘‘early relapse”, i.e., re-
currence of fever within several days after completion of antibi-
otic therapy, is occasionally observed when antibiotic therapy 
is discontinued before the development of the protective im-
munity. In addition, ‘‘prolonged convalescence”, i.e., persistent 
vague symptoms such as weakness in the absence of fever, as 
shown in patients 1 and 2, was clarified to be associated with 
the presence of O. tsutsugamushi in blood. This complication 
seems to occur as a result of slow development of the immuni-
ty. ‘‘Late relapse”, i.e., recurrence of scrub typhus several months 
or years after the initial O. tsutsugamushi infection, is surely pos-
sible. Reactivation of dormant O. tsutsugamushi infection is doc-
umented in mice after inoculation of heterologous strain of O. tsu-
tsugamushi or treatment with cyclophosphamide (14); in hu-
mans, coinfection of scrub typhus and leptospirosis (22), espe-
cially in patients not accompanied with eschar, may represent 
reactivation of scrub typhus triggered by leptospirosis.
  Although it is not certain whether occurrence of the TIA in 
patient 4 and aggravation of coronary artery disease in patient 6 
are related with persistent O. tsutsugamushi infection, these cases 
raise the necessity of long-term follow-up of scrub typhus pa-
tients, especially if they have multiple risk factors for atheroscle-
rosis. O. tsutsugamushi is a representative bacterium infecting 
vascular endothelium, and infection may be one of risk factors 
for progression of atherosclerosis (23). Furthermore, antibiotics 
cannot eradicate O. tsutsugamushi, so once O. tsutsugamushi 
infection occurs, its effect may persists for a long time.
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